Contribution By Saipriya Iyer
With more than four million people infected by novel coronavirus across the globe, the need for the COVID-19 vaccine is of paramount importance today. Companies worldwide have developed several polemical candidate vaccines for COVID-19 which are curr
OSE Immunotherapeutics, a clinical-stage biotechnology company based in Nantes, France, has selected CLEC-1 for its oral presentation at the second Virtual Annual Meeting of American Association of Cancer Research (AACR). After conducting research, C
KFC has recently announced that it will be opening about 16 of its restaurants for the customers looking to pick their orders up in person. The chain had been opened for delivery and drive-thru previously.
In the U.K., takeaway cafes and restaurants
American drug development company based, Novavax has recently announced that it has successfully identified an optimal antidote candidate for COVID-19. As planned, the firm is about to move forward with its next stage of human trials.
According to r
The U.S. FDA has reportedly provided a new guidance for investigators and developers of therapeutics & preventive agents, as well as recommendations amid the coronavirus pandemic.
Shared on 12th May, the guidance provides a streamlined process f
San Francisco ice-cream major Smitten Ice-cream has lately partnered with Perfect Day, a company from Emeryville, CA, prominent for producing flora made dairy protein. The collaboration aims to develop a product called ‘Smitten N’Ice Crea
Tecno has recently unveiled a delivery to the doorstep initiative in India. The company’s network of retail shops that consists of more than 35,000 outlets scattered in the country will be delivering the smartphones to the doorstep of the consu
The Indian Council of Medical Research (ICMR), has reportedly given the approval for the clinical trials of convalescent plasma therapy at the King Edward Memorial (KEM) Hospital. The doctors have been hopeful for the therapy to be effective in savin
Keck Medicine will reportedly launch a clinical trial to study an anti-inflammatory drug’s effects on the COVID-19 infected patients. The baricitinib drug has been approved by the FDA to treat patients with rheumatoid arthritis.
According to D